Two‐stage designs for cross‐over bioequivalence trials
- 24 March 2015
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 34 (16) , 2403-2416
Abstract
The topic of applying two‐stage designs in the field of bioequivalence studies has recently gained attention in the literature and in regulatory guidelines. While there exists some methodological research on the application of group sequential designs in bioequivalence studies, implementation of adaptive approaches has focused up to now on superiority and non‐inferiority trials. Especially, no comparison of the features and performance characteristics of these designs has been performed, and therefore, the question of which design to employ in this setting remains open. In this paper, we discuss and compare ‘classical’ group sequential designs and three types of adaptive designs that offer the option of mid‐course sample size recalculation. A comprehensive simulation study demonstrates that group sequential designs can be identified, which show power characteristics that are similar to those of the adaptive designs but require a lower average sample size. The methods are illustrated with a real bioequivalence study example. Copyright © 2015 John Wiley & Sons, Ltd.Keywords
This publication has 29 references indexed in Scilit:
- An Insight into the Properties of a Two-Stage Design in Bioequivalence StudiesPharmaceutical Research, 2013
- Group sequential and discretized sample size re-estimation designs: a comparison of flexibilityStatistics in Medicine, 2012
- Comments on ‘Adaptive increase in sample size when interim results are promising: A practical guide with examples’Statistics in Medicine, 2011
- Adaptive designs for confirmatory clinical trialsStatistics in Medicine, 2009
- Evaluating the adaptive performance of flexible sample size designs with treatment difference in an intervalStatistics in Medicine, 2007
- The design of simulation studies in medical statisticsStatistics in Medicine, 2006
- Assessment of futility in clinical trialsPharmaceutical Statistics, 2006
- A general statistical principle for changing a design any time during the course of a trialStatistics in Medicine, 2004
- A group sequential approach to crossover trials for average bioequivalenceJournal of Biopharmaceutical Statistics, 1997
- The role of internal pilot studies in increasing the efficiency of clinical trialsStatistics in Medicine, 1990